Skip to main content
Premium Trial:

Request an Annual Quote

Japanese Pharma Signs Up For Five Celera Databases

Premium

R

OCKVILLE, Md.--Celera Genomics has signed an agreement with Takeda Chemical Industries of Osaka, Japan, that provides a five-year comprehensive subscription to five Celera databases, including its bioinformatics tools and browsers. The Japanese company is now subscribing to Celera's Human Gene Index, SNP database and databases for the Drosophila, human, and mouse genomes. Takeda says it is the largest pharmaceutical company in Japan. It is a research-based global company focused mainly on pharmaceuticals.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.